TrialJournal of viral hepatitis2021
Farnesoid X receptor agonist for the treatment of chronic hepatitis B: A safety study.
Robin Erken et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
26 papers cite it
this paperpooled ittrialcites it